Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach
Condition: Suicidal Ideation Interventions: Drug: Estradiol Transdermal Patch 0.1 mg/24 hrs; Drug: Oral Micronized Progesterone 200mg; Drug: Inactive Clear Patch; Drug: Placebo capsule Sponsor: University of Illinois at Chicago Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials